Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Icariin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107641621B reveals a dual-enzyme method for Icaritin. Achieve 98.3% conversion with thermostable glycosidases for cost-effective manufacturing.
Patent CN107163014B reveals a novel lanthanide-catalyzed route for icariine. Achieve high purity and scalable manufacturing with our advanced pharmaceutical intermediates supply chain solutions.